U.S. market Closed. Opens in 3 hours 6 minutes

ELTX | Elicio Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312013-12-312012-12-31
RevenueN/AN/A28.31M2.88M1.49M4.03M6.58M7.30M
Cost of Revenue1.17M1.06M1.23M1.82M1.14M380.00K3.17M3.67M
Gross Profit-1.17M-1.06M27.08M1.06M351.00K3.65M3.41M3.62M
Operating Expenses34.58M23.73M25.47M15.72M12.34M17.99M3.81M4.04M
Selling, General & Admin11.90M5.63M7.54M3.00M2.80M8.84M3.61M4.04M
Research & Development22.68M18.10M17.93M12.72M9.54M9.15M196.01KN/A
Other Operating ExpensesN/AN/AN/AN/AN/AN/AN/AN/A
Operating Income-35.74M-23.73M-25.47M-15.72M-12.34M-14.34M-397.80K-419.22K
Other Expenses / Income550.00K-4.47M-926.01K8.94K-28.32M-5.68M2.13M1.61M
Before Tax Income-35.20M-28.21M-26.40M-15.71M-12.26M-20.02M1.73M1.19M
Income Tax ExpensesN/A3.60M876.44K8.94K81.48KN/A452.78K201.86K
Net Income-35.20M-28.21M-26.40M-15.71M-12.26M-20.02M632.24K307.30K
Interest Expenses1.06M3.60M876.44KN/AN/AN/A300.43K307.45K
Basic Shares Outstanding5.06M3.10M3.20M8.15M8.15M2.95M6.12K6.12K
Diluted Shares Outstanding5.06M3.10M3.20M8.15M8.15M2.95M6.12K6.12K
EBITDA-32.97M-23.55M-51.92M-15.53M-40.16M-14.34M62.54K1.96M
EBITDA Margin0.00%0.00%-183.40%-539.15%-2,700.87%-355.92%0.95%26.92%
EBIT-34.14M-21.02M-24.65M-15.70M-12.18M-20.02M1.39M816.61K
EBIT Margin0.00%0.00%-87.06%-545.25%-819.06%-497.02%21.05%11.19%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312013-12-312012-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙